GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Apimeds Pharmaceuticals US

APUS 3.25 -4.69%

Close of 21 October 2026, in USD — never converted.

Apimeds Pharmaceuticals US — daily APUS Delayed

Chart and prices are provided by TradingView. Global Banking & Finance Review publishes no price data on this page. Nothing here is investment advice. How we cover markets.

Other Health Care listings

Latest on Apimeds Pharmaceuticals US

Frequently asked questions

What is Apimeds Pharmaceuticals US's ticker?

Apimeds Pharmaceuticals US trades as APUS on its US listing, under ISIN US03771D1028.

What was Apimeds Pharmaceuticals US's last closing price?

3.25 on 21 October 2026. The figure is in USD and is never converted.

Does Global Banking & Finance Review publish price data for Apimeds Pharmaceuticals US?

We publish the closing prices we record ourselves, in the currency the instrument trades in. Charts and live quotes come from TradingView. Nothing on this page is investment advice.